Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Hemophagocytic Syndrome
Interventions
DRUG

Patients diagnosed with HLH-94 should be treated as soon as possible

For some highly suspicious patients, after diagnosis, according to the patient's etiology, the treatment plan should be determined as soon as possible, such as lymphoma-related patients treated with hormones combined with etoposide, which can greatly improve the prognosis of patients

Trial Locations (1)

221006

RECRUITING

Affilitated Hospital of Xuzhou Medical University, Xuzhou

All Listed Sponsors
lead

The Affiliated Hospital of Xuzhou Medical University

OTHER